FIELD: medicine.
SUBSTANCE: invention is a crystallomorphological method of pancreatic tumour diseases diagnosis, comprising ninhydrin administration to the patient's urine sample with hemlock and gentian tincture addition, mixture drying by evaporation, arbitrary selection of 3 fractals, for which the mean fractal scale value is calculated F = P/S1/2, where P is perimeter, S is fractal area, and at F value of 4.0 to 5.5, the absence of tumour or the presence of a slowly growing tumour is concluded, at F value of 5.6 to 7.5, the presence of a benign or an incarnating malignant tumour is concluded, at F value of 7.6 to 9.0, the presence of a malignant tumour is concluded, and at F value greater than 9.0, the presence of cancer and metastasis appearance is concluded.
EFFECT: invention provides tumour diseases and disease stages diagnosis.
2 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
CRYSTALLOMORPHOLOGICAL METHOD FOR TUMOR DISEASES DIAGNOSIS AND PREVENTION | 2015 |
|
RU2623077C2 |
CRYSTAL-MORPHOLOGICAL DIAGNOSTIC TECHNIQUE FOR RENAL ONCOLOGICAL DISEASES | 2014 |
|
RU2542498C1 |
DIAGNOSTIC TECHNIQUE FOR TUMOURS AND CENTRAL NERVOUS SYSTEM DISEASES | 2010 |
|
RU2441241C1 |
RF HYPERTHERMIA DEVICE FOR PERSONALIZED TREATMENT AND DIAGNOSIS | 2013 |
|
RU2626899C2 |
METHOD OF APOPTOSIS STIMULATION | 2006 |
|
RU2340349C2 |
KERATOMA REMOVAL TECHNIQUE | 2013 |
|
RU2522959C1 |
DIAGNOSTICS AND TREATMENT OF MALIGNANT TUMOURS OF PANCREAS, OVARIES AND OTHER MALIGNANT TUMOURS | 2009 |
|
RU2556129C2 |
DIAGNOSTIC TECHNIQUE FOR MALIGNANT PROCESS IN HUMAN BODY | 2009 |
|
RU2417056C1 |
METHOD FOR EVALUATING THE DISEASE OCCURRENCE IN PATIENTS WITH NON-HODGKIN'S LYMPHOMAS | 2006 |
|
RU2319148C1 |
METHOD TO TREAT TUMORS | 1994 |
|
RU2112530C1 |
Authors
Dates
2017-04-18—Published
2015-10-12—Filed